Dr. Daniel S. Berman[email protected]Nuclear MedicineScreening for CAD in diabetics: Which patient? Which test?Screening for coronary artery disease (CAD) in any population is controversial. In this editorial opinion, Dr. Daniel Berman of Cedars-Sinai Medical Center points out what he believes are shortcomings in the Detection of Ischemia in Asymptomatic Diabetics (DIAD) study published this week in the Journal of the American Medical Association.April 16, 2009Page 1 of 1Top StoriesMRIMRI-based model shows changes over time in multiple myeloma patientsWhole-body MRI could serve as a scalable biomarker for risk stratification in multiple myeloma patients.UltrasoundThyroid nodule classification systems provide diagnostic equityInterventionalY-90 TARE rises to top in treatments for liver transplant patientsUltrasoundUltrasound MinnieCast, Episode 16: How to create a sonography associationISeConsult systems may benefit radiology-provider communication